Share ownership InterCure Ltd.

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 14:44:26 28/08/2026 +04			5-day change	1st Jan Change
1,764.00 ^ILa	+3.10%		+34.55%	+9.02%

08-25	InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
08-24	Intercure Ltd. Finalizes Settlement for War-Related Indirect Damages with the Israeli Tax Authorities and Compensation Fund the Subsequent War	CI

Share class: InterCure Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,845,711	7,205,378 ( 60.83 %)	0	60.83 %

Major shareholders: InterCure Ltd.

Name	Stocks	%	Valuation
Alexander Rabinovitch 5.002 %	2,962,512	5.002 %	3 M ILa
Yael Figel 1.39 %	823,389	1.39 %	847 012 ILa
Yaron Jacobi 1.285 %	761,083	1.285 %	782 918 ILa
IBI Mutual Funds Management (1978) Ltd. 0.1758 %	104,138	0.1758 %	107 126 ILa
Amos Cohen 0.1553 %	92,000	0.1553 %	94 639 ILa
Ayalon Mutual Funds Ltd. 0.0722 %	42,779	0.0722 %	44 006 ILa
Healthcare of Ontario Pension Plan Trust Fund 0.0718 %	42,500	0.0718 %	43 719 ILa
Psagot Mutual Funds Ltd. 0.0527 %	31,201	0.0527 %	32 096 ILa
KSM Mutual Funds Ltd. 0.044 %	26,049	0.044 %	26 796 ILa
Citadel Securities GP LLC 0.0364 %	21,583	0.0364 %	22 202 ILa
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	7.83%
Institutional	0.44%
Others	0.12%
Unknown	91.61%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	7.83%
Israel	0.36%
United States	0.13%
Canada	0.07%

Based on 1000 largest holdings

InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.

Employees

285

Sector

Healthcare Facilities & Services

More about the company